(3R,4S)-4-Amino-1-methylpyrrolidin-3-ol dihydrochloride, 98%, 500mg

N-(2-METHYLPHENYLMETHYL)ISOPROPYLAMINE, 97%, 10g

METHYL 3-BROMOQUINOLINE-6-CARBOXYLATE, 95.0%, 10g

tert-Butyl octahydro-1,5-naphthyridine-1(2H)-carboxylate, 95.0%, 250mg

Fmoc-(S)-3-Amino-4-(2-bromo-phenyl)-butyric acid, 97%, 5g

[4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic Acid>99.0%(HPLC)(T)5g

(S)-2,3-Dihydroxypropyl 4-methylbenzenesulfonate, 1g

(3-Formyl-indol-1-yl)-acetic acid, 97.0%, 1g

(1-methyl-1H-benzimidazol-2-yl)methanol, 95.0%, 10g

rEGCase II1vial

(3-Methoxy-4-methylphenyl)methanol, 95.0%, 5g

(3-methyl-4,5-dihydro-1H-pyrazol-1-yl)acetic acid hydrochloride, 95.0%, 1g

Ethyl5-[[[[3'-(Methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl][(2,4,6-trimethylphenyl)sulfonyl]amino]methyl]-2-furancarboxylate, 98%, 250mg